Kaiser H - Search Results

1

Treatment of hypertension with a beta-adrenoceptor blocker. A multicentre trial with pindolol.

Rosenthal J, Kaiser H, Raschig A, Welzel D. Rosenthal J, et al. Among authors: kaiser h. Br J Clin Pract. 1979 Jun;33(6):165-74, 181. Br J Clin Pract. 1979. PMID: 393291 Clinical Trial. No abstract available.

2

[The practice of hypertensive therapy using a beta receptor blocker. A multicentric study using 15 mg Visken].

Rosenthal J, Kaiser H, Hammerschmidt D, Welzel D. Rosenthal J, et al. Among authors: kaiser h. Med Welt. 1977 Dec 2;28(48):1969-74. Med Welt. 1977. PMID: 600069 German. No abstract available.

3

[A new antihypertensive agent used in a clinical setting].

Wetzels E, Raschig A, Kaiser HJ. Wetzels E, et al. Among authors: kaiser hj. Med Klin. 1980 Sep 12;75(19):688-92. Med Klin. 1980. PMID: 7001207 Clinical Trial. German.

4

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.

Przuntek H, Welzel D, Blümner E, Danielczyk W, Letzel H, Kaiser HJ, Kraus PH, Riederer P, Schwarzmann D, Wolf H, et al. Przuntek H, et al. Among authors: kaiser hj. Eur J Clin Pharmacol. 1992;43(4):357-63. doi: 10.1007/BF02220609. Eur J Clin Pharmacol. 1992. PMID: 1451713 Clinical Trial.

5

[Evaluation of the prevention of perioperative thromboembolism with low molecular weight heparin and dihydroergotamine. A study of the incidence of lethal pulmonary embolisms and undesired symptoms, especially the risk of vasospasm and myocardial infarction].

Wolf H, Welzel D, Kaiser H, Majer M, Schäfer D, Husfeldt KJ, Voigt J, Sunder-Plassmann L. Wolf H, et al. Among authors: kaiser h. Arzneimittelforschung. 1988 Oct;38(10):1516-9. Arzneimittelforschung. 1988. PMID: 3196393 German.

6

Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

Przuntek H, Welzel D, Gerlach M, Blümner E, Danielczyk W, Kaiser HJ, Kraus PH, Letzel H, Riederer P, Uberla K. Przuntek H, et al. Among authors: kaiser hj. J Neural Transm (Vienna). 1996;103(6):699-715. doi: 10.1007/BF01271230. J Neural Transm (Vienna). 1996. PMID: 8836932 Clinical Trial.

7

[Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].

Werning C, Hammerschmidt D, Kaiser Hj. Werning C, et al. Among authors: kaiser hj. Med Welt. 1978 Oct 6;29(40):1570-5. Med Welt. 1978. PMID: 703579 Clinical Trial. German. No abstract available.

8

[The effect and tolerance of a gall-enzyme preparation].

Gross W, Kaiser HJ. Gross W, et al. Among authors: kaiser hj. Med Welt. 1978 Jan 27;29(4):144-9. Med Welt. 1978. PMID: 345040 Clinical Trial. German. No abstract available.

9

[Management of congestive edema by saluretics].

Fischer H, Rietsch R, Kaiser H. Fischer H, et al. Among authors: kaiser h. Med Welt. 1975 May 23;26(21):1054-7. Med Welt. 1975. PMID: 1143073 German. No abstract available.

10

[Effect of norepinephrine and strophantin on the venous blood volume diagram in the leg].

Fischer H, Rietsch R, Kaiser H, Matis P. Fischer H, et al. Among authors: kaiser h. Med Welt. 1974 May 31;25(22):995-7. Med Welt. 1974. PMID: 4409379 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

882 results

Search Page